Annual Revenue
$2.79 B
+$400.35 M+16.73%
December 31, 2024
Summary
- As of March 11, 2025, AMRX annual revenue is $2.79 billion, with the most recent change of +$400.35 million (+16.73%) on December 31, 2024.
- During the last 3 years, AMRX annual revenue has risen by +$700.29 million (+33.45%).
- AMRX annual revenue is now at all-time high.
Performance
AMRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$730.52 M
+$28.05 M+3.99%
December 31, 2024
Summary
- As of March 11, 2025, AMRX quarterly revenue is $730.52 million, with the most recent change of +$28.05 million (+3.99%) on December 31, 2024.
- Over the past year, AMRX quarterly revenue has stayed the same.
- AMRX quarterly revenue is now at all-time high.
Performance
AMRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.79 B
+$113.54 M+4.24%
December 31, 2024
Summary
- As of March 11, 2025, AMRX TTM revenue is $2.79 billion, with the most recent change of +$113.54 million (+4.24%) on December 31, 2024.
- Over the past year, AMRX TTM revenue has stayed the same.
- AMRX TTM revenue is now at all-time high.
Performance
AMRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AMRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.7% | 0.0% | 0.0% |
| 3 y3 years | +33.5% | 0.0% | 0.0% |
| 5 y5 years | +71.8% | 0.0% | 0.0% |
AMRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.5% | at high | +46.8% | at high | +33.5% |
| 5 y | 5-year | at high | +71.8% | at high | +83.9% | at high | +71.8% |
| alltime | all time | at high | +174.4% | at high | +186.8% | at high | +975.1% |
Amneal Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.79 B(+16.7%) | $730.52 M(+4.0%) | $2.79 B(+4.2%) |
| Sep 2024 | - | $702.47 M(+0.1%) | $2.68 B(+3.2%) |
| Jun 2024 | - | $701.78 M(+6.5%) | $2.60 B(+4.1%) |
| Mar 2024 | - | $659.19 M(+6.8%) | $2.50 B(+4.2%) |
| Dec 2023 | $2.39 B(+8.2%) | $616.98 M(-0.5%) | $2.39 B(+0.3%) |
| Sep 2023 | - | $620.04 M(+3.5%) | $2.39 B(+3.2%) |
| Jun 2023 | - | $599.05 M(+7.4%) | $2.31 B(+1.7%) |
| Mar 2023 | - | $557.54 M(-8.6%) | $2.27 B(+2.7%) |
| Dec 2022 | $2.21 B(+5.7%) | $609.76 M(+11.8%) | $2.21 B(+3.4%) |
| Sep 2022 | - | $545.56 M(-2.5%) | $2.14 B(+0.8%) |
| Jun 2022 | - | $559.36 M(+12.4%) | $2.12 B(+1.2%) |
| Mar 2022 | - | $497.63 M(-7.3%) | $2.10 B(+0.2%) |
| Dec 2021 | $2.09 B(+5.1%) | $536.90 M(+1.6%) | $2.09 B(+1.3%) |
| Sep 2021 | - | $528.59 M(-1.2%) | $2.07 B(+0.5%) |
| Jun 2021 | - | $535.08 M(+8.5%) | $2.06 B(+3.5%) |
| Mar 2021 | - | $493.11 M(-3.3%) | $1.99 B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $1.99 B(+22.5%) | $510.03 M(-1.8%) | $1.99 B(+6.0%) |
| Sep 2020 | - | $519.29 M(+11.8%) | $1.88 B(+8.1%) |
| Jun 2020 | - | $464.66 M(-6.8%) | $1.74 B(+3.6%) |
| Mar 2020 | - | $498.53 M(+25.5%) | $1.68 B(+3.2%) |
| Dec 2019 | $1.63 B(-2.2%) | $397.33 M(+5.0%) | $1.63 B(-5.8%) |
| Sep 2019 | - | $378.28 M(-6.5%) | $1.73 B(-5.4%) |
| Jun 2019 | - | $404.64 M(-9.3%) | $1.82 B(-0.5%) |
| Mar 2019 | - | $446.12 M(-10.3%) | $1.83 B(+10.3%) |
| Dec 2018 | $1.66 B(+60.9%) | $497.53 M(+4.4%) | $1.66 B(+14.0%) |
| Sep 2018 | - | $476.49 M(+15.2%) | $1.46 B(+17.9%) |
| Jun 2018 | - | $413.79 M(+50.4%) | $1.24 B(+14.2%) |
| Mar 2018 | - | $275.19 M(-6.2%) | $1.08 B(+34.1%) |
| Dec 2017 | $1.03 B(+1.5%) | $293.37 M(+15.2%) | $807.97 M(+57.0%) |
| Sep 2017 | - | $254.73 M(-2.0%) | $514.60 M(+98.0%) |
| Jun 2017 | - | $259.87 M | $259.87 M |
| Dec 2016 | $1.02 B | - | - |
FAQ
- What is Amneal Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual revenue year-on-year change?
- What is Amneal Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
- What is Amneal Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM revenue year-on-year change?
What is Amneal Pharmaceuticals annual revenue?
The current annual revenue of AMRX is $2.79 B
What is the all time high annual revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual revenue is $2.79 B
What is Amneal Pharmaceuticals annual revenue year-on-year change?
Over the past year, AMRX annual revenue has changed by +$400.35 M (+16.73%)
What is Amneal Pharmaceuticals quarterly revenue?
The current quarterly revenue of AMRX is $730.52 M
What is the all time high quarterly revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly revenue is $730.52 M
What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, AMRX quarterly revenue has changed by $0.00 (0.00%)
What is Amneal Pharmaceuticals TTM revenue?
The current TTM revenue of AMRX is $2.79 B
What is the all time high TTM revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM revenue is $2.79 B
What is Amneal Pharmaceuticals TTM revenue year-on-year change?
Over the past year, AMRX TTM revenue has changed by $0.00 (0.00%)